Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 501–600 of 1,392
Amoebic liver abscess: a report from central India
Chaudhary, S., Noor, M. T., Jain, S., et al. (2015) · Tropical Doctor · doi:10.1177/0049475515592283 · Cited by 21
Ткаченко, П. І., Kriukova, G., Aleksandrova, M., Chertov, О., Renard, É., & Pereverzev, S. V. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.07.003 · Cited by 23
“According to a report of a Workgroup of the American Diabetes Association and the Endocrine Society [1] hypoglycemia is defined as blood glucose (BG) level less than 70 mg/dL. Nocturnal hypoglycemia (NH) is the most feared type of hypoglycemia in patients with diabetes treated by insulin.”
BackgroundInfluentialBoulin, M., Diaby, V., & Tannenbaum, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162951 · Cited by 22
Sampson, M., Bailey, M., Clark, J., Evans, M. L., Fong, R., Hall, H., Hambling, C. E., Hadley‐Brown, M., Morrish, N. J., Murphy, H. R., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.017 · Cited by 26
Ruan, Y., Bally, L., Thabit, H., Leelarathna, L., Hartnell, S., Tauschmann, M., Wilinska, M. E., Evans, M. L., Mader, J. K., Kojzar, H., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13304 · Cited by 22
“It may be accompanied by sweating, trembling and confusion, and may require assistance from another person.(2) Insulin pump therapy has been shown to reduce glycated haemoglobin levels without increasing the risk of hypoglycaemia.”
BackgroundIntranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Pontiroli, A. E., & Ceriani, V. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13317 · Cited by 22
“Severe hypoglycaemia (SH) is defined as a circumstance that requires the assistance of a third party to treat the episode.(4) SH occurs more frequently in individuals with T1D than in those with T2D,(3,8) in individuals under intensive insulin treatment,(2,9) and in the elderly,(10) with a different risk depending on…”
BackgroundPedersen‐Bjergaard, U., Alsifri, S. N., Aronson, R., Berković, M. C., Galstyan, G. R., Gydesen, H., Lekdorf, J. B., Ludvik, B. H., Moberg, E., Ramachandran, A., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13588 · Cited by 25
“The definitions of hypoglycaemia varied widely among studies (Table S2) and only the HAT,(15) DIALOG(16), survey of self-reported insulin adherence(22) and HypoAna(33,34) studies defined hypoglycaemia in accordance with ADA definitions.(35) Documentation was based primarily on symptoms, while a limited number of studi…”
ResultXu, Y., Wang, Q., Wu, Z., Lu, K., Cheng, X., Jin, W., & Zhao, Y. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.019 · Cited by 21
Urakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., Suzuki, J., & Morioka, I. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0193 · Cited by 24
“Moreover, the relationship between TIR and severe or moderate hypoglycemia has been reported [17-21].”
BackgroundCurrent State and Evidence of Cellular Encapsulation Strategies in Type 1 Diabetes
Marfil‐Garza, B. A., Polishevska, K., Pepper, A. R., & Korbutt, G. S. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190033 · Cited by 24
Hompesch, M., Morrow, L., Watkins, E., Roepstorff, C., Thomsen, H. F., & Haahr, H. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.12.014 · Cited by 20
Pratley, R. E., Emerson, S. S., Franek, E., Gilbert, M. P., Marso, S. P., McGuire, D. K., Pieber, T. R., Zinman, B., Hansen, C. T., Hansen, M. V., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13699 · Cited by 25
“Severe hypoglycaemia has been shown to be associated with a higher risk of adverse cardiovascular (CV) events and mortality.(7,8) In addition, severe hypoglycaemic episodes can increase utilization of healthcare resources.”
BackgroundMethodDerivation and validation model for hospital hypoglycemia
Ena, J., Gaviria, A. Z., Romero-Sánchez, M., Carretero‐Gómez, J., Carrasco-Sánchez, F. J., Segura, J., Porto-Pérez, A. B., Vázquez-Rodríguez, P., González-Becerra, C., & Gómez‐Huelgas, R. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.08.024 · Cited by 20
Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes
Kreider, K. E., Pereira, K. C., & Padilla, B. I. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0325-9 · Cited by 22
“Table 2 Classifications of hypoglycemia in diabetes [19]”
BackgroundInfluentialEvans, M., Mehta, R., Gundgaard, J., & Chubb, B. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0478-1 · Cited by 22
DeVries, J. H., Bailey, T. S., Bhargava, A., Gerety, G., Gumprecht, J., Heller, S. R., Lane, W. S., Wysham, C., Zinman, B., Bak, B. A., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13565 · Cited by 24
“1 mmol/L [56 mg/dL]) symptomatic episodes; nocturnal symptomatic hypoglycaemia was defined as severe or BGconfirmed episodes in the time interval of 00:01 to 05:59 AM, both inclusive; severe hypoglycaemia was defined as events requiring thirdparty assistance, based on the ADA definition.(27) All severe episodes report…”
MethodSelf-citationDysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia
Kilberg, M. J., Sheikh, S., Stefanovski, D., Kubrak, C., León, D. D. D., Hadjiliadis, D., Rubenstein, R. C., Rickels, M. R., & Kelly, A. T. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.07.006 · Cited by 25
“Hypoglycemia was defined as plasma glucose <70mg/dL during MMTT, based upon the standard definition of the American Diabetes Association and Endocrine Society and recommendations by Armaghanian et al [13, 26] and used to assign participants to exposure groups for analysis.”
MethodClopidogrel drug interactions: a review of the evidence and clinical implications
Lee, C. H., Franchi, F., & Angiolillo, D. J. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1814254 · Cited by 23
Personal Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older
Argento, N. B., & Nakamura, K. (2014) · Endocrine Practice · doi:10.4158/ep14017.or · Cited by 23
Cross-linked nanofilms for tunable permeability control in a composite microdomain system
Biswas, A., Nagaraja, A. T., You, Y., Roberts, J. R., & McShane, M. J. (2016) · RSC Advances · doi:10.1039/c6ra13507b · Cited by 18
Ohashi, Y., Wolden, M. L., Hyllested-Winge, J. L., & Brod, M. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12642 · Cited by 21
“Category: (1) Original article Title: The diabetes management and daily functioning burden of non-severe hypoglycaemia in Japanese people treated with insulin Short running title: Non-severe hypoglycaemia impact Japan Authors: Yasuo Ohashi(1), Michael Lyng Wolden(2), Jacob Hyllested-Winge(3), Meryl Brod(4)”
BackgroundSchwandt, A., Bergis, D., Dapp, A., Ebner, S., Jehle, P. M., Köppen, S., Risse, A., Zimny, S., & Holl, R. W. (2015) · Journal of Diabetes Research · doi:10.1155/2015/792968 · Cited by 24
“Severe hypoglycemia was defined as an event requiring assistance of another person [17].”
BackgroundSotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
Powell, D. R., Doree, D. D., Jeter-Jones, S. L., Ding, Z., Zambrowicz, B., & Sands, A. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s76342 · Cited by 20
Mantovani, A., Grani, G., Chioma, L., Vancieri, G., Giordani, I., Rendina, R., Rinaldi, M. E., Andreadi, A., Coccaro, C., Boccardo, C., et al. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.08.004 · Cited by 19
Nattero‐Chávez, L., Pascual, E. L., de la Villa, E. D. L. C., Cebada, A. B., Ruiz, T., Tobar, A. Q., Lorenzo, M., Sánchez, C., Izquierdo, A., Luque‐Ramírez, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110627 · Cited by 19
Artifactual Hypoglycemia: An Old Term for a New Classification
Tarasova, V. D., Zena, M., & Rendell, M. (2014) · Diabetes Care · doi:10.2337/dc13-2891 · Cited by 19
Insulin Therapy in Type 1 Diabetes
Stephens, E. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.016 · Cited by 25
Raju, A., Shetty, S. S., Cai, B., & D’Souza, A. O. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.5.483 · Cited by 19
Hypoglycemia During Therapy of Diabetes
Spanakis, E. K., Cryer, P. E., & Davis, S. N. (2015) · Europe PMC (PubMed Central) · Cited by 21
Self-citationAssociation between mild and severe hypoglycemia in people with type 2 diabetes initiating insulin
Festa, A., Heller, S. R., Seaquist, E. R., Duan, R., Hadjiyianni, I., & Fu, H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.12.014 · Cited by 20
Self-citationOrthodontic Treatment Consideration in Diabetic Patients
Almadih, A., Al-Zayer, M., Dabel, S., Alkhalaf, A. H., Mayyad, A. A., Bardisi, W., Alshammari, S. B., & Alsihati, Z. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3285w · Cited by 22
“Dentists as well as orthodontic team should be well-trained to early identify and manage hypoglycemia [22, 23].”
BackgroundBrown‐Frandsen, K., Emerson, S. S., McGuire, D. K., Pieber, T. R., Poulter, N. R., Pratley, R. E., Zinman, B., Ranthe, M. F., Grøn, R., Lange, M., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13677 · Cited by 18
Lim, S. K., Ku, E. J., Lee, S. Y., Lee, J. H., Lee, J.-E., Kim, K. M., & Davies, M. J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000807 · Cited by 26
Kyi, M., Gorelik, A., Reid, J. E. A., Rowan, L. M., WRAIGHT, P. R., Colman, P. G., & Fourlanos, S. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.06.006 · Cited by 20
Ando, Y., Shigiyama, F., Hirose, T., & Kumashiro, N. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13533 · Cited by 19
Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment
Wright, E. E., & Subramanian, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0191 · Cited by 20
“35 Hollander et al. recently reported findings from subgroup analyses that evaluated risk factors for clinically relevant hypoglycemia in 319 elderly T2D patients ( ‡ 65 years) treated with basal insulin.”
Takagi, S., Miura, J., Takita, M., Mochizuki, S., Asanuma, T., Hoshina, S., Takaike, H., Uchigata, Y., & Babazono, T. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13886 · Cited by 20
EINHORN, D. F., Handelsman, Y., Bode, B. W., Endahl, L. A., Mersebach, H., & King, A. B. (2015) · Endocrine Practice · doi:10.4158/ep14523.or · Cited by 18
Senthilkumaran, M., Zhou, X.-F., & Bobrovskaya, L. (2016) · International Journal of Endocrinology · doi:10.1155/2016/9801640 · Cited by 19
“It should be emphasised that the HAAF phenomenon is distinct from the classic diabetic autonomic neuropathy, a common complication of diabetes [53].”
BackgroundZhu, L., Ang, L. C., Tan, W. B., Xin, X., Bee, Y. M., Goh, S., & Teh, M. M. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817707422 · Cited by 19
Cryer, P. E., & Arbeláez, A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch35 · Cited by 26
Self-citationHeller, S. R., DeVries, J. H., Wysham, C., Hansen, C. T., Hansen, M. V., & Frier, B. M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13708 · Cited by 18
“Severe hypoglycaemia is of even greater concern, as it has been shown to be associated with increased risk of cardiovascular events and mortality.(10,11) As with non-severe events, severe episodes can increase utilization of healthcare resources, with adverse economic consequences.”
BackgroundSelf-citationDávila-Rúales, V., Córdoba, L. F. G., Medina, A. M. G., Múñoz, Ó., Serrano, M. N., & Henao, D. C. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241304459 · Cited by 22
Hypoglycemia in Older Patients
Hoogwerf, B. J. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.001 · Cited by 21
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 26
Cardiopulmonary exercise testing during pregnancy
Wowdzia, J. B., & Davenport, M. H. (2020) · Birth Defects Research · doi:10.1002/bdr2.1796 · Cited by 22
“It is important to measure values before and after exercise to ensure the patient does not develop hypoglycemia ( 3.3 mmol/L) (Seaquist et al., 2013).”
BackgroundInfluentialNeurological Complications of Endocrine Emergencies
Cruz‐Flores, S. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01105-2 · Cited by 20
Gap junction coupling and islet delta-cell function in health and disease
MIRANDA, C. A., Samad, M., Vergari, E., & Briant, L. J. B. (2021) · Peptides · doi:10.1016/j.peptides.2021.170704 · Cited by 24
Li, S., Li, Y., Zhang, L., Bi, Y., Zou, Y., Liu, L., Zhang, H., Yuanyuan, Gong, W., & Zhang, Y. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01839-y · Cited by 21
Wang, W., Agner, B. F. R., Luo, B., Liu, L., Liu, M. R., Peng, Y., Qu, S., Stachlewska, K., Wang, G., Yuan, G., et al. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13286 · Cited by 26
Klen, J., Goričar, K., Janež, A., & Dolžan, V. (2014) · BioMed Research International · doi:10.1155/2014/934729 · Cited by 21
“Hypoglycemia events were classified into five groups according to American Diabetes Association criteria: (1) severe hypoglycemia, (2) documented symptomatic hypoglycemia, (3) asymptomatic hypoglycemia, (4) probable symptomatic hypoglycemia, and (5) relative hypoglycemia [25, 26].”
Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts
Tan, M. B., & McAdory, L. E. (2016) · Journal of Radiology Case Reports · doi:10.3941/jrcr.v10i3.2686 · Cited by 19
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Mittermayer, F., Caveney, E. J., OLIVEIRA, C. D. F., Fleming, G. A., Gourgiotis, L., Puri, M., Tai, L.-J., & Turner, J. R. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666160413115655 · Cited by 20
Kramer, G., Michalak, L., Müller, U., Kloos, C., Werner, C., & Kuniß, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0875-3988 · Cited by 23
Tschanz, M. P., Watts, S. A., Colburn, J. A., Conlin, P. R., & POGACH, L. M. (2017) · Europe PMC (PubMed Central) · Cited by 20
Curtin, F., Champion, B. L., Davoren, P. M., Duke, S., Ekinci, E. I., Gilfillan, C. P., Morbey, C., Nathow, T., O'Moore‐Sullivan, T. M., O'Neal, D. N., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14010 · Cited by 18
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 19
Meier, J. J., Granhall, C., Hövelmann, U., Navarria, A., Plum‐Mörschel, L., Ramesh, C. K., Tannapfel, A., & Kapitza, C. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14632 · Cited by 20
“There were no reports of severe hypoglycaemic episodes, based on the American Diabetes Association classification of an event that requires the assistance of another person.(27) No clinically relevant changes in vital signs, laboratory parameters, physical examination or electrocardiogram were observed.”
MethodWu, W., Li, Y., Chen, X., Lin, D., Xiang, S., Shen, F., & Gu, X. (2015) · Medical Science Monitor · doi:10.12659/msm.894026 · Cited by 18
“Hypoglycemia was defined according to American Diabetes Association guidelines [17].”
MethodOlveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal‐Casariego, A., Irigoyen, C. A., Olivares, J., Conde-García, M. D. C., García‐Manzanares, Á., et al. (2014) · Nutrition · doi:10.1016/j.nut.2014.04.023 · Cited by 26
Herrmann, K., Zhou, M., Wang, A., & de Bruin, T. W. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0030-z · Cited by 21
“It has been recognized that the risk of hypoglycemia is one of the most significant factors that limit optimization of insulin therapy [30, 31].”
BackgroundSevere Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes
Lee, A. K., McEvoy, J. W., Hoogeveen, R. C., Ballantyne, C. M., & Selvin, E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.049 · Cited by 18
Jeon, J. Y., Kim, S. R., Kim, H. J., Kim, D. J., Lee, K. W., Lee, J.-D., & Han, S. J. (2016) · Medicine · doi:10.1097/md.0000000000005365 · Cited by 22
“The American Diabetes Association and the Endocrine Society Workgroup on Hypoglycemia recommend the following classifications for hypoglycemia in patients with diabetes: severe hypoglycemia, documented symptomatic hypoglycemia, asymptomatic hypoglycemia, probable symptomatic hypoglycemia, and pseudohypoglycemia.([9])…”
BackgroundInfluentialKristensen, P. L., Tarnow, L., Bay, C., Nørgaard, K., Jensen, T., Parving, H. ‐., Perrild, H., Beck‐Nielsen, H., Christiansen, J. S., Thorsteinsson, B., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13317 · Cited by 22
Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes
Zhong, V. W., Crandell, J., Shay, C. M., Gordon‐Larsen, P., Cole, S. R., Juhaeri, J., Kahkoska, A. R., Maahs, D. M., Seid, M., Forlenza, G. P., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.017 · Cited by 20
Bacha, F. F., ghormli, L. K. E., Arslanian, S. A., Zeitler, P. S., Laffel, L. M., Katz, L. E. L., Gandica, R., CHANG, N. T., Sprague, J., MacLeish, S. A., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12906 · Cited by 18
DAILEY, G. E., & Lavernia, F. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12531 · Cited by 17
Bally, L., Thabit, H., Tauschmann, M., Allen, J. M., Hartnell, S., Wilinska, M. E., Exall, J., Huegel, V., Sibayan, J., Borgman, S. K., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016738 · Cited by 17
Cost Analysis of FreeStyle Libre® 2 System in Type 2 Diabetes Mellitus Population
Oyagüez, I., Peralta, F. G., Artola, S., Carrasco-Sánchez, F. J., Carretero‐Gómez, J., Soidán, F. J. G., Gómez‐Huelgas, R., Merino-Torres, J. F., & Pérez, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01064-4 · Cited by 26
“those requiring help from another person [29, 30].”
Ritsinger, V., Hagström, E., Lagerqvist, B., & Norhammar, A. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022667 · Cited by 22
“In patients without diabetes, glucose levels between 2 and 11 mmol/L (36– 198 mg/dL) were categorized in the following 5 groups according to the definitions of hypoglycemia 21 and the World Health Organization”
Wowdzia, J. B., Hazell, T. J., & Davenport, M. H. (2022) · Physiological Reports · doi:10.14814/phy2.15454 · Cited by 21
“…the American Diabetes Association and the Endocrine Society Working Group, our cutoff for hypoglycemia in pregnant individuals was defined as glucose values <3.3 mmol/L, and hyperglycemia was defined as values ≥7.8 mmol/L (in alignment for 1 h postprandial target values; Seaquist et al., 2013).”
BackgroundInfluentialChen, Y., Yang, C., Huang, L.-C., Chen, L., & Hwu, C. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.04.002 · Cited by 20
Treatment of Mild Hypoglycemia
Evert, A. B. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.58 · Cited by 17
Severe Hypoglycemia and the Role of the Significant Other: Expert, Sentry, and Protector
King, J., Overland, J., Fisher, M., & White, K. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715606223 · Cited by 21
Jian-wei, Z., & Zhou, Y.-J. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0245-z · Cited by 16
“9 mmol/l (70 mg/dl) [7].”
Cha, S., Yun, J., Lim, T., Kang, Y., Lee, K., Song, K., Yoo, K., Park, Y., Ko, S., & Ahn, Y. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.463 · Cited by 18
Goh, S., Hussein, Z. B., & Rudijanto, A. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12647 · Cited by 20
How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting
Kulasa, K. M., & Juang, P. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0902-3 · Cited by 21
Thong, E. P., Wong, P., Dev, A. T., Ebeling, P. R., Teede, H. J., & Milat, F. (2017) · Clinical Endocrinology · doi:10.1111/cen.13488 · Cited by 17
“Hypoglycaemia is a complication of insulin therapy in T1DM and leads to considerable morbidity and psychological distress (23).”
BackgroundInfluentialSafety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump
Thrasher, J., Surks, H., Nowotny, I., Pierre, S., Rotthaeuser, B., Wernicke-Panten, K., & Garg, S. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817753644 · Cited by 17
“Hypoglycemic episodes were categorized based on American Diabetes Association classifications.(10-12) Documented hypoglycemia was defined as PG ≤70 mg/dl and separately as PG <54 mg/dl.”
MethodPieber, T. R., Švehlíková, E., Brunner, M., Halberg, I. B., Thomsen, K. M. D., & Haahr, H. L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13767 · Cited by 17
Wei, Y., Lin, F., Lin, S., & Wang, C. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1556 · Cited by 19
“The drug interaction between repaglinide and clopidogrel could cause a negative impact on the care of patients with diabetes: the occurrence of hypoglycemia could impair patients’ quality of life, become a barrier to treatment escalation for better glucose control, and even be life-threatening.(9) In addition, patient…”
BackgroundTherapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
Pontiroli, A. E., & Tagliabue, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153646 · Cited by 17
Visser, S. A. G., Kandala, B., Fancourt, C., Krug, A. W., & Cho, C. R. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1729 · Cited by 19
Takahara, S., Ikeda, K., Fujimoto, S., Asai, K., Oguri, Y., Harashima, S., Tsuji, H., Shide, K., & Inagaki, N. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12360 · Cited by 18
Bae, J. P., Duan, R., Fu, H., & Hoogwerf, B. J. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.07.037 · Cited by 18
Is testing for postprandial hyperinsulinemic hypoglycemia after gastric bypass necessary?
Gasser, M., Meier, C., Herren, S., Reber, E., Steffen, R., & Stanga, Z. G. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.11.013 · Cited by 19
Venturini, M., Sallemi, C., Marra, P., Palmisano, A., Agostini, G., Lanza, C., Balzano, G., Falconi, M., Secchi, A., Fiorina, P., et al. (2018) · Gland Surgery · doi:10.21037/gs.2017.11.12 · Cited by 16
Gomes, M. B., Santos, D. C., Pizarro, M., Melo, L. G. N., Barros, B. S. V., Montenegro, R. M., Fernandes, V. O., & Negrato, C. A. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01308-7 · Cited by 17
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14208 · Cited by 17
“As in DEVOTE, severe hypoglycaemia was defined in accordance with the 2013 ADA criteria.(31)”
BackgroundMethodInfluentialSelf-citationHenriksen, M. M., Andersen, H. U., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2021) · Diabetologia · doi:10.1007/s00125-020-05360-9 · Cited by 19
“The experience of hypoglycaemia is generally believed to affect people with diabetes in a negative manner [1, 2].”
BackgroundMosenzon, O., Miller, E. M., & Warren, M. L. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1800286 · Cited by 16
Pedersen‐Bjergaard, U., Agesen, R. M., Brøsen, J. M. B., Alibegovic, A. C., Andersen, H. U., Beck‐Nielsen, H., Gustenhoff, P., Hansen, T. K., Hedetoft, C., Jensen, T. J., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14574 · Cited by 16
“The secondary endpoints are the incidence of severe hypoglycaemia (total, night time, daytime) as defined by the American Diabetes Association as an event requiring the assistance of another person to actively administer carbohydrates, glucagon, or to take other corrective actions.(18) Overall glycaemic control, as as…”
BackgroundPilla, S. J., Kraschnewski, J. L., Lehman, E. B., Kong, L., Francis, E., Poger, J. M., Bryce, C. L., Maruthur, N. M., & Yeh, H.-C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002153 · Cited by 16
O'Neal, D. N., Cohen, O., Vogrin, S., Vigersky, R. A., Jenkins, A. J., McAuley, S. A., Lee, M. H., Paldus, B., Sims, C. M., MacIsaac, R. J., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0350 · Cited by 16
Self-citationHuang, J., Peng, W., Ding, S., Xiong, S., & Liu, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-24822-1 · Cited by 22
Brož, J., Brabec, M., Žďarská, D. J., Fedáková, Z., Pospíšilová, L., You, J., Doničová, V., Hlaďo, P., Rahelić, D., Kvapil, M., et al. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87393 · Cited by 16
“Definition of SH used in the questionnaire An episode characterized by symptoms typical of hypoglycemia and requiring assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions.(6) Even though patient education regarding hypoglycemia is part of the standard treatment…”
MethodEfficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
Ohmura, H., Mita, T., Taneda, Y., Sugawara, M., Funayama, H., Matsuoka, J., Watada, H., & Daida, H. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1983w · Cited by 17
“Generally, it was reported that the use of glucose-lowering agents, old age, renal dysfunction, long duration of type 2 diabetes, aggressive therapy and obesity increased hypoglycemic events [37, 38].”
BackgroundEmons, M. F., Bae, J. P., Hoogwerf, B. J., Kindermann, S. L., Taylor, R., & Nathanson, B. H. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000160 · Cited by 20
“10 Although only a portion of severe hypoglycemic episodes present to the emergency room (ER) or hospital, 11 resource utilization related to these events re fl ect the signi fi cant burden on the healthcare system.”
BackgroundType 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges
Blumer, I. R., & CLEMENT, M. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.020 · Cited by 18
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.